Sage Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Sage Therapeutics is a publicly traded company on NGM using the ticker symbol SAGE.
Detailed information on company financials and operating reports can be found here:
NGM: SAGE
Note: Sage Therapeutics's revenues are gauged from an analysis of company filings.
Investor Activity
Sage Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
January 15, 2021
1
100%
$650 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Sage Therapeutics is developing and marketing.
Sage Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
DALKEMPY Pharmaceutical preparations
01/24/2024
YUREMBY Pharmaceutical preparations
01/24/2024
JOIZEMO Pharmaceutical preparations
01/24/2024
See all trademarks and details in the Full Report.
Market Share of Sage Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Sage Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Sage Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Sage Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.